Farmakokinetiske data fra mere end 2000 postmenopausale kvinder, inklusive patienter i udvalgte osteoporose- studier, har dannet grundlag for en populationsfarmakokinetisk analyse.
Pharmacokinetic data from over 2,000 postmenopausal women including patients in selected osteoporosis clinical trials contributed to a population pharmacokinetic analysis.